Only higher-dose Alb therapy (2.5 g/kg) significantly improved the neurological score and reduced total infarct volume (by 32%) at 24 h compared to vehicle rats, when administered at 2 h after onset of stroke. This evidence concerns the gene ALB and stroke disorder.